dpp-4 inhibitor and glp-1 receptor agonist combination not recommended guideline agonists or inhibitors: How to guide the clinician? Prescribing pearls: A guide to

Check your GLP-1 receptor gene variants linked to weight loss response

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

A recent study tracked self-reported GLP-1 side effects among Reddit users and found several overlooked side effects like chills and hot flashes linked to weight loss medications like Ozempic and Mounjaro.

All Day

Retatrutide vs Semaglutide: Evidence-based comparison of the investigational triple GIP/GLP-1/glucagon agonist versus the FDA-approved GLP-1 agonist

A-RDN induced significant increases in diuretic and natriuretic responses to GLP-1 in HF (urine flow 96.01.9 vs